Skip to contentSkip to filters

We use cookies for analytics.

The New ERA in Alzheimer Diagnosis and Treatment

John C. Morris

Washington University School of Medicine

Abstract

John Morris examines how blood-based biomarkers and anti-amyloid therapies have changed the clinical evaluation of early symptomatic Alzheimer disease. He discusses the role of timely and accurate diagnosis in identifying patients who may benefit from treatment.

Topics